Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;46(6):1303-1318.
doi: 10.1007/s10529-024-03517-9. Epub 2024 Jul 27.

Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants

Affiliations

Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants

Flavia Fagiani et al. Biotechnol Lett. 2024 Dec.

Abstract

Objectives: The aim of this work was to rapidly produce in plats two recombinant antigens (RBDw-Fc and RBDo-Fc) containing the receptor binding domain (RBD) of the spike (S) protein from SARS-CoV-2 variants Wuhan and Omicron as fusion proteins to the Fc portion of a murine IgG2a antibody constant region (Fc).

Results: The two recombinant antigens were expressed in Nicotiana benthamiana plants, engineered to avoid the addition of N-linked plant-typical sugars, through vacuum agroinfiltration and showed comparable purification yields (about 35 mg/kg leaf fresh weight).

Conclusions: Their Western blotting and Coomassie staining evidenced the occurrence of major in planta proteolysis in the region between the RBD and Fc, which was particularly evident in RBDw-Fc, the only antigen bearing the HRV 3C cysteine protease recognition site. The two RBD N-linked glycosylation sites showed very homogeneous profiles free from plant-typical sugars, with the most abundant glycoform represented by the complex sugar GlcNAc4Man3. Both antigens were specifically recognised in Western Blot analysis by the anti-SARS-CoV-2 human neutralizing monoclonal antibody J08-MUT and RBDw-Fc was successfully used in competitive ELISA experiments for binding to the angiotensin-converting enzyme 2 receptor to verify the neutralizing capacity of the serum from vaccinated patients. Both SARS-Cov-2 antigens fused to a murine Fc region were rapidly and functionally produced in plants with potential applications in diagnostics.

Keywords: COVID19; Molecular farming; Proteolytic degradation; SARS-CoV-2; Transient expression.

PubMed Disclaimer

Similar articles

References

    1. Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, Manenti A, Pantano E, Kabanova A, Troisi M, Vacca F, Cardamone D, De Santi C, Torres JL, Ozorowski G, Benincasa L, Jang H, Di Genova C, Depau L, Brunetti J, Agrati C, Capobianchi MR, Castilletti C, Emiliozzi A, Fabbiani M, Montagnani F, Bracci L, Sautto G, Ross TM, Montomoli E, Temperton N, Ward AB, Sala C, Ippolito G, Rappuoli R (2021) Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell 184:1821–1835. https://doi.org/10.1016/j.cell.2021.02.035 - DOI - PubMed - PMC
    1. Capell T, Twyman RM, Armario-Najera V, Ma JK, Schillberg S, Christou P (2020) Potential applications of plant biotechnology against SARS-CoV-2. Trends Plant Sci 25:635–643. https://doi.org/10.1016/j.tplants.2020.04.009 - DOI - PubMed - PMC
    1. Ceballo Y, López A, González CE, Ramos O, Andújar I, Martínez RU, Hernández A (2022) Transient production of receptor- binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice. Mol Biol Re 49:6113–6123. https://doi.org/10.1007/s11033-022-07402-4 - DOI
    1. Diego-Martin B, González B, Vazquez-Vilar M, Selma S, Mateos-Fernández R, Gianoglio S, Fernández-del-Carmen A, Orzáez D (2020) Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities. Front Plant Sci 11:612781. https://doi.org/10.3389/fpls.2020.612781 - DOI - PubMed - PMC
    1. Donini M, Marusic C (2019) Current state-of-the-art in plant-based antibody production systems. Biotechnol Lett 41:335–346. https://doi.org/10.1007/s10529-019-02651-z - DOI - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources